Witnessing Anaphylaxis in public: Would you know what to do? 25th August 2026

What should you do if someone has anaphylaxis? We are often asked this on our helpline by people with allergies, as well as parents, friends, family members and members of the public….

Read more
Immunotherapy treatment for house dust mite allergy now available through NHS Scotland  13th August 2026

An immunotherapy treatment for house dust mite allergy has been made available through the NHS in Scotland.  The Scottish Medicines Consortium (SMC) has accepted Acarizax (12 SQ-HDM sublingual immunotherapy) for adults aged 18–65 with moderate…

Read more
Climbing for Greg: Brother takes on Mount Kilimanjaro in memory of sibling lost to anaphylaxis 10th August 2026

When Josh begins his ascent of Mount Kilimanjaro later this year in aid of Anaphylaxis UK, every step he takes up Africa’s highest peak will be in memory of his brother Greg,…

Read more
Fundraiser Andrew sets sights on remote Hengduan summit to support Anaphylaxis UK and Cancer Research UK 4th August 2026

19-year-old Andrew is preparing to take on one of China’s most remote peaks in an extraordinary expedition that could make him the first recorded British climber to reach its summit, all while…

Read more
Sharing pupil allergy information: New guidance for schools ahead of Benedict’s Law 3rd August 2026

With Benedict’s Law coming into force this September, schools across the country are preparing for new safeguarding responsibilities while ensuring compliance with data protection legislation. However, an overly cautious approach to GDPR…

Read more
Support for adults with food and non-food allergy 10th July 2026

Food and non-food allergies are often associated with childhood, but millions of adults across the UK live with allergies too. Around 6% of the UK adult population has a clinically confirmed food…

Read more
Department of Education publishes new statutory guidance on allergies in schools 6th July 2026

Following the Government’s announcement earlier this year of new allergy guidance to help keep children safe in schools, the Department for Education has now published its statutory guidance. The new requirements will…

Read more
Lower dose EURneffy® nasal adrenaline spray approved by MHRA for younger children 30th June 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four…

Read more
Anaphylaxis UK welcomes launch of Natasha’s Prize 22nd June 2026

The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community.  As a charity supporting…

Read more